15-55495583-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_130810.4(DNAAF4):​c.271+2129G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.889 in 152,108 control chromosomes in the GnomAD database, including 60,981 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.89 ( 60981 hom., cov: 30)

Consequence

DNAAF4
NM_130810.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.39

Publications

4 publications found
Variant links:
Genes affected
DNAAF4 (HGNC:21493): (dynein axonemal assembly factor 4) This gene encodes a tetratricopeptide repeat domain-containing protein. The encoded protein interacts with estrogen receptors and the heat shock proteins, Hsp70 and Hsp90. An homologous protein in rat has been shown to function in neuronal migration in the developing neocortex. A chromosomal translocation involving this gene is associated with a susceptibility to developmental dyslexia. Mutations in this gene are associated with deficits in reading and spelling. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream cell cycle progression 1 (CCPG1) gene. [provided by RefSeq, Mar 2011]
DNAAF4-CCPG1 (HGNC:43019): (DNAAF4-CCPG1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring dyslexia susceptibility 1 candidate 1 (DYX1C1) and cell cycle progression 1 (CCPG1) genes on chromosome 15. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.959 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_130810.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF4
NM_130810.4
MANE Select
c.271+2129G>A
intron
N/ANP_570722.2
DNAAF4
NM_001033560.2
c.271+2129G>A
intron
N/ANP_001028732.1
DNAAF4
NM_001033559.3
c.271+2129G>A
intron
N/ANP_001028731.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF4
ENST00000321149.7
TSL:1 MANE Select
c.271+2129G>A
intron
N/AENSP00000323275.3
DNAAF4
ENST00000448430.6
TSL:1
c.271+2129G>A
intron
N/AENSP00000403412.2
DNAAF4
ENST00000457155.6
TSL:1
c.271+2129G>A
intron
N/AENSP00000402640.2

Frequencies

GnomAD3 genomes
AF:
0.889
AC:
135125
AN:
151990
Hom.:
60916
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.967
Gnomad AMI
AF:
0.968
Gnomad AMR
AF:
0.810
Gnomad ASJ
AF:
0.869
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.807
Gnomad FIN
AF:
0.878
Gnomad MID
AF:
0.905
Gnomad NFE
AF:
0.903
Gnomad OTH
AF:
0.878
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.889
AC:
135249
AN:
152108
Hom.:
60981
Cov.:
30
AF XY:
0.882
AC XY:
65538
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.967
AC:
40129
AN:
41512
American (AMR)
AF:
0.810
AC:
12366
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.869
AC:
3016
AN:
3472
East Asian (EAS)
AF:
0.424
AC:
2179
AN:
5142
South Asian (SAS)
AF:
0.809
AC:
3886
AN:
4806
European-Finnish (FIN)
AF:
0.878
AC:
9297
AN:
10592
Middle Eastern (MID)
AF:
0.905
AC:
266
AN:
294
European-Non Finnish (NFE)
AF:
0.903
AC:
61373
AN:
67996
Other (OTH)
AF:
0.878
AC:
1854
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
688
1377
2065
2754
3442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.880
Hom.:
2848
Bravo
AF:
0.884
Asia WGS
AF:
0.665
AC:
2309
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.49
DANN
Benign
0.31
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4255730; hg19: chr15-55787781; API